PPARG and Hepatic fibrosis: An antifibrotic effect of an ARB (Telmisartan), which is an angiotensin 1 (AT) receptor blocker and a PPARγ partial agonist, was demonstrated in both acute and chronic stages of a Schistosoma-mansoni-induced liver fibrosis mouse model [38].